Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Amortization of Deferred Charges (2021 - 2025)

Historic Amortization of Deferred Charges for Core Scientific (CORZ) over the last 5 years, with Q3 2025 value amounting to $1.3 million.

  • Core Scientific's Amortization of Deferred Charges fell 1841.94% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.5 million, marking a year-over-year decrease of 451.26%. This contributed to the annual value of $3.8 million for FY2024, which is 39946.81% up from last year.
  • As of Q3 2025, Core Scientific's Amortization of Deferred Charges stood at $1.3 million, which was down 1841.94% from $1.6 million recorded in Q2 2025.
  • Core Scientific's Amortization of Deferred Charges' 5-year high stood at $6.2 million during Q4 2021, with a 5-year trough of -$190000.0 in Q4 2024.
  • Its 5-year average for Amortization of Deferred Charges is $1.5 million, with a median of $1.2 million in 2022.
  • Per our database at Business Quant, Core Scientific's Amortization of Deferred Charges surged by 135376.88% in 2022 and then crashed by 12526.6% in 2024.
  • Quarter analysis of 5 years shows Core Scientific's Amortization of Deferred Charges stood at $6.2 million in 2021, then crashed by 84.59% to $963000.0 in 2022, then dropped by 21.91% to $752000.0 in 2023, then crashed by 125.27% to -$190000.0 in 2024, then soared by 790.0% to $1.3 million in 2025.
  • Its Amortization of Deferred Charges was $1.3 million in Q3 2025, compared to $1.6 million in Q2 2025 and $1.7 million in Q1 2025.